Variant report
Variant | esv3416302 |
---|---|
Chromosome Location | chr1:77099714-77101662 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr1:77101474-77101854 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr1:77101388-77101876 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr1:77101512-77101827 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr1:77101262-77101931 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | JUN | chr1:77101632-77101735 | HepG2 | liver: | n/a | chr1:77101660-77101673 |
6 | JUND | chr1:77101562-77101749 | HepG2 | liver: | n/a | n/a |
7 | MAFF | chr1:77100652-77100884 | K562 | blood: | n/a | chr1:77100785-77100803 |
8 | MAFF | chr1:77100624-77100964 | HepG2 | liver: | n/a | chr1:77100785-77100803 |
9 | MAFK | chr1:77100619-77100976 | HepG2 | liver: | n/a | chr1:77100792-77100802 |
10 | MAFK | chr1:77100671-77100904 | Hela-S3 | cervix: | n/a | chr1:77100792-77100802 |
11 | MAFK | chr1:77100631-77100957 | IMR90 | lung: | n/a | chr1:77100792-77100802 |
12 | MAFK | chr1:77100654-77100951 | K562 | blood: | n/a | chr1:77100792-77100802 |
13 | MAFK | chr1:77100654-77100952 | HepG2 | liver: | n/a | chr1:77100792-77100802 |
14 | MYC | chr1:77101441-77101941 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | MYC | chr1:77101404-77101826 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr1:77101357-77101557 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | STAT3 | chr1:77101510-77101783 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | STAT3 | chr1:77101449-77101875 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | STAT3 | chr1:77101498-77101816 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | STAT3 | chr1:77101428-77101816 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000272855 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151125116 | chr1:77099714-77099715 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140188345 | chr1:77099720-77099721 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556652500 | chr1:77099770-77099771 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556355253 | chr1:77099821-77099822 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574630349 | chr1:77099828-77099829 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143870928 | chr1:77099858-77099859 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75807779 | chr1:77099947-77099948 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560128377 | chr1:77099952-77099953 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571962558 | chr1:77099984-77099985 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374573455 | chr1:77100011-77100012 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539081302 | chr1:77100037-77100038 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552496921 | chr1:77100039-77100040 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545753123 | chr1:77100042-77100043 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146848686 | chr1:77100065-77100066 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527365788 | chr1:77100124-77100125 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531842731 | chr1:77100158-77100159 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189177817 | chr1:77100171-77100172 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61771670 | chr1:77100189-77100190 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs529377886 | chr1:77100206-77100207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs61771671 | chr1:77100207-77100208 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs369308754 | chr1:77100226-77100227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140642542 | chr1:77100244-77100245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568751982 | chr1:77100287-77100288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539472214 | chr1:77100327-77100328 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551708024 | chr1:77100337-77100338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201969503 | chr1:77100347-77100348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs341018 | chr1:77100349-77100350 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs367970021 | chr1:77100376-77100377 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112171097 | chr1:77100378-77100379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112874978 | chr1:77100379-77100380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556420207 | chr1:77100517-77100518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574668955 | chr1:77100520-77100521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369941989 | chr1:77100527-77100528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535604055 | chr1:77100534-77100535 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553604551 | chr1:77100535-77100536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572058190 | chr1:77100627-77100628 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs180756897 | chr1:77100636-77100637 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs563727946 | chr1:77100646-77100647 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs576378084 | chr1:77100647-77100648 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs543689036 | chr1:77100648-77100649 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs372026540 | chr1:77100649-77100650 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs529482334 | chr1:77100679-77100680 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs150124486 | chr1:77100692-77100693 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs61771672 | chr1:77100705-77100706 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs551527199 | chr1:77100724-77100725 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs576067747 | chr1:77100763-77100764 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs570042168 | chr1:77100767-77100768 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs373423158 | chr1:77100779-77100780 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs77277876 | chr1:77100792-77100793 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs171017 | chr1:77100828-77100829 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:77098600-77106200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr1:77098800-77100200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr1:77099400-77100200 | Flanking Active TSS | Primary T cells from cord blood | blood |
4 | chr1:77100200-77102800 | Enhancers | Primary T cells from cord blood | blood |
5 | chr1:77101400-77102000 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr1:77101400-77102000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |